Inhibition of endothelial cell survival and angiogenesis by protein kinase A

Journal of Clinical Investigation

Volumn 110, Issue 7, 2002, Pages 933-941

  Kim, Semi ^a   Bakre, Manjiri ^a   Yin, Hong ^a   Varner, Judith A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA5 INTEGRIN; BETA1 INTEGRIN; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE;

ANGIOGENESIS; APOPTOSIS; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM;

EID: 0036792466     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI0214268     Document Type: Article

References (46)

1. Varner, J.A. 1997. The role of vascular cell integrin αvβ3 and αvβ5 in angiogenesis. EXS. 79:361-390.
2. Asahara, T., et al. 1999. VEGF contributes to postnatal neovascularization by mobilizing bone marrow derived endothelial progenitor cells. EMBO J. 18:3964-3972.
3. Meredith, J.E., Jr., Fazeli, B., and Schwartz, M.A. 1993. The ECM as a cell survival factor. Mol. Biol. Cell. 4:953-961.
4. Brooks, P.C., et al. 1994. Integrin αvβ3 antagonists promote tumor regression by inducing apoptosis ofangiogenic blood vessels. Cell. 79:1157-1164.
5. Boudreau, N., Sympson, C.J., Werb, Z., and Bissell, M. 1995. Suppression of ICE and apoptosis in mammary epithelial cells by ECM. Science. 267:891-893.
6. Stromblad, S., Becker, J.C., Yebra, M., Brooks, P.C., and Cheresh, D.A. 1996. Suppression of p53 activity and p21WAF1/CIP1 expression by vascular cell integrin αvβ3 during angiogenesis. J. Clin. Invest. 98:426-433.
7. Clark, R.A.F., Tonneson, M.G., Gailit, J., and Cheresh, D.A. 1996. Transient functional expression of αvβ3 on vascular cells during wound repair. Am. J. Path. 148:1407-1421.
8. Friedlander, M., et al. 1995. Definition of two angiogenic pathways by distinct alpha v integrins. Science. 270:1500-1502.
9. Arap, W., Pasqualini, R., and Ruoslahti, E. 1997. Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model. Science. 279:377-380.
10. Brooks, P.C., Clark, R.A., and Cheresh, D.A. 1994. Requirement of vascular integrin alpha v beta 3 for angiogenesis. Science. 264:569-571.
11. Carron, C.P., et al. 1998. A peptidomimetic antagonist of the integrin αvβ3 inhibits Leydig cell tumor growth and development of hypercalcemia of malignancy. Cancer Res. 58:1930-1955.
12. Christofidou-Solomidou, M., Bridges, M., Murphy, G., Albelda, S., and DeLisser, H.M. 1997. Expression and function of endothelial cell αv integrin receptors in wound-induced human angiogenesis in human skin/SCID mice chimeras. Am. J. Path. 151:975-983.
13. Drake, C.J., Cheresh, D.A., and Little, C.D. 1995. An antagonist of integrin αvβ3 prevents maturation of blood vessels during embryonic neovascularization. J. Cell Sci. 108:2655-2661.
14. Friedlander, M., et al. 1996. Involvement ofintegrin αvβ3 and αvβ5 in ocular neovascular diseases. Proc. Natl. Acad. Sci. USA. 93:9764-9769.
15. Varner, J.A., Nakata, M.T., Jordan, R.E., and Coller, B.S. 1999. Inhibition of angiogenesis and tumor growth by murine 7E3, the parent antibody of c7E3 Fab (abciximab; ReoPro™). Angiogenesis. 3:53-61.
16. Bader, B.L., Rayburn, H., Crowley, D., and Hynes, R.O. 1998. Extensive vasculogenesis, angiogenesis, and organogenesis precede lethality in mice lacking all αv integrins. Cell. 95:507-520.
17. Kim, S., Bell, K., Mousa, S., and Varner, J.A. 2000. Regulation of angiogenesis in vivo by ligation of integrin α5β1 with the central cell binding domain of fibronectin. Am. J. Path. 156:1345-1362.
18. Kloss, C., et al. 1999. Integrin family of cell adhesion molecules in the injured brain: regulation and cellular localization in the normal and regenerating mouse facial motor nucleus. J. Comp. Neurol. 411:162-178.
19. Kim, S., Harris, M., and Varnet, J.A. 2000. Regulation of integrin αvβ3-mediated endothelial cell migration and angiogenesis by integrin α5β1 and protein kinase A.J. Biol Chem. 275:33920-33928.
20. Varner, J.A., Emerson, D.A., and Juliano, R.L. 1995. Integrin α5β1 expression negatively regulates cell growth: reversal by attachment to fibronectin. Mol. Biol. Cell. 6:725-740.
21. Giancotti, F.G., and Ruoslahti, E. 1990. Elevated levels of alpha 5 beta 1 fibronectin receptor suppress the transformed phenotype of Chinese hamster ovary cells. Cell. 60:849-859.
22. Plath, T., et al. 2000. A novel function for the tumor suppressor p16INK4a: induction of anoikis via upregulation of the α5β1 fibronectin receptor. J. Cell. Biol. 150:1467-1477.
23. George, E. L., Georges, E.N., Patel-King, R.S., Rayburn, H., and Hynes, R.O. 1993. Defects in mesodermal migration and vascular development in fibronectin-deficient mice. Development 119:1079-1091.
24. Yang, J.T., Rayburn, H., and Hynes, R.O. 1993. Embryonic mesodermal defects in α5 integrin-deficient mice. Development. 119:1093-1105.
25. Goh, K.L., Yang, J.T., and Hynes, R.O. 1997. Mesodermal defects and cranial neural crest apoptosis in α5 integrin-null embryos. Development. 124:4309-4319.
26. Yatohgo, T., Izumi, M., Kashiwagi, H., and Hayashi, M. 1988. Novel purification of vitronectin from human plasma by heparin affinity chromatography. Cell Struct. Funct 13:281-292.
27. Herrmann, M., et al. 1994. A rapid and simple method for the isolation of apoptotic DNA fragments. Nucleic Acids Res. 22:5506-5507.
28. Dormond, O., Foletti, A., Paroz, C., and Rüegg, C. 2001. NSAIDs inhibit alpha V beta 3 integrin-mediated and Cdc42/Rac-dependent endothelialcell spreading, migration and angiogenesis. Nat. Med. 7:1041-1047.
29. Raynal, P., and Pollard, H. B. 1994. Annexins: the problem of assessing the biological role for a gene family of multifunctional calcium and phospholipid-binding proteins. Biochem. Biophys. Acta. 1197:63-93.
30. Nicholson, D.W., et al. 1995. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature. 376:37-43.
31. Partel, T., Gores, G.J., and Kaufmann, S.H. 1996. The role of protease during apoptosis. FASEB J. 10:587-597.
32. Leaveley, D.I., Schwartz, M.A., Rosenfeld, M., and Cheresh, D.A. 1993. Integrin β1 and β3-mediated endothelial cell migration is triggered through distinct mechanisms. J. Cell Biol. 121:163-170.
33. Johnson, A.L., and Bridgham, J.T. 2000. Caspase-3 and -6 expression and enzyme activity in hen granulosa cells. Biol. Reprod. 62:589-598.
34. Montgomery, A.M.P, Reisfeld, R.A., and Cheresh, D.A. 1994. Integrin αvβ3 rescues melanoma from apoptosis in a three-dimensional dermal collagen. Proc. Natl. Acad. Sci. USA. 91:8856-8860.
35. Ashkenazi, A., and Dixit, V.M. 1998. Death receptors: signaling and modulation. Science. 281:1305-1308.
36. Thornberry, N., and Lazebik, Y. 1998. Caspases: enemies within. Science. 281:1312-1316.
37. Schwartz, M.A. 1997. Integrins, oncogenes and anchorage independence. J. Cell Biol. 139:575-578.
38. Frisch, S.M., and Francis, H. 1994. Disruption of epithelial cell-matrix interactions induces apoptosis. J. Cell. Biol. 124:619-626.
39. Rytomaa, M., Martins, L.M., and Downward,J. 1999. Involvement of FADD and caspase 8 signaling in detachment induced apoptosis. Curr. Biol. 9:1043-1046.
40. Magnusson, M.K., and Mosher, D.F. 1998. Fibronectin: structure, assembly, and cardiovascular implications. Arterioscler. Thromb. Vasc. Biol. 18:1363-1370.
41. Stupack, D.G., Puente, X.S., Butsaboualoy, S., Storgard, C.M., and Cheresh, D.A. 2001. Apoptosis of adherent cells by recruitment of caspase-8 to unligated integrins. J. Cell Biol. 155:459-470.
42. Weissinger, E., et al. 1997. Inhibition of Raf-1 kinase by cyclic AMP agonists causes apoptosis of v-abl-transformed cells. Mol. Cell. Biol. 17:3229-3241.
43. D'Angelo, G., Lee, H., and Weiner, R.I. 1997. CAMP-dependent protein kinase inhibits the mitogenic action of vascular endothelial growth factor and fibroblast growth factor in capillary endothelial cells by blocking Raf activation. J. Cell. Biochem. 67:353-366.
44. Srivastava, R.K., et al. 1998. Involvement of microtubules in the regulation of Bcl-2 phosphorylation and apoptosis through cyclic AMP-dependent protein kinase. Mol. Cell. Biol. 18:3509-3517.
45. Zhang, Z., Vuori, K., Reed,J.C., and Ruoslahti, E. 1995. The α5β1 integrin supports survival of cells on fibronectin and upregulates bcl-2 expression. Mol. Biol. Cell. 6:841-850.
46. Kim, S., Jee, K., Kim, D., Koh, H., and Chung, J. 2001. Cyclic AMP inhibits Akt activity by blocking the membrane localization of PDK1. J. Biol. Chem. 276:12864-12870.